As an interventional radiologist at Palmetto General Hospital, I have over 15 years of experience treating venous ...
The AMBULATE Same-Day Discharge Clinical Study Series demonstrates safe and effective use of VASCADE MVP in three studies to date, with more than 800 AF ablation patients discharged the same calendar ...
More than three quarters of patients with chronic limb-threatening ischemia (CLTI) and no revascularization options were able to avoid above-the-ankle amputation through a new technique called ...
InterVene Receives FDA 510(k) Clearance for Recana®, the First Fully Integrated Thrombectomy System for Venous In-Stent Restenosis and Native Vessel Obstructions Recana Thrombectomy Catheter System is ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved a transcatheter deep venous arterialization system for treatment of chronic limb-threatening ...
Approximately 20% of patients with chronic limb-threatening ischemia have no revascularization options, leading to above-ankle amputation. Transcatheter arterialization of the deep veins is a ...
Penumbra announced the launch of the Lightning Flash 3.0 computer assisted vacuum thrombectomy (CAVT) system for the ...
Early recognition of chronic venous insufficiency helps improve outcome and reduces the need for surgical intervention. Chronic venous insufficiency (CVI) affects 10% to 35% of adults in the United ...
EATONTOWN, N.J.--(BUSINESS WIRE)--Venarum Medical, LLC today announced receipt of a mentorship grant in further support of its awarded Phase II SBIR Grant “EVVS: EndoVenous Valve System” currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results